Based in Sunnyvale, CA, Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.

Sunnyvale, US
Size (employees)
1,700 (est)
Cepheid was founded in 1996 and is headquartered in Sunnyvale, US

Cepheid Office Locations

Cepheid has an office in Sunnyvale
Sunnyvale, US (HQ)
904 Building 1 E Caribbean Dr

Cepheid Metrics

Cepheid Financial Metrics

Revenue (2015)

$538.6 m

Revenue growth (2014-15), %


Gross profit

$268.7 m

Gross profit margin (2015), %


Net income (2015)

($48.5 m)

Market capitalization (04-Nov-2016)

$3.9 b

Closing share price (04-Nov-2016)


Cash (31-Dec-2015)

$112.6 m
Cepheid's current market capitalization is $3.9 b.
Cepheid's revenue was reported to be $538.6 m in FY, 2015 which is a 14.6% increase from the previous period.
FY, 2013FY, 2014FY, 2015


$401.3 m$470.1 m$538.6 m

Revenue growth, %


Cost of goods sold

$207.9 m$229.3 m$269.9 m

Gross profit

$193.4 m$240.8 m$268.7 m

Gross profit Margin, %


Operating expense total

$209.4 m$274.9 m$299.6 m


($16 m)($34.1 m)($30.9 m)

EBIT margin, %


Interest expense

$137 k$12.6 m$14.7 m

Interest income

$45 k$1.1 m$1.9 m

Pre tax profit

($16.8 m)($47.6 m)($47.3 m)

Income tax expense

($1.1 m)($2.6 m)($1.3 m)

Net Income

($18 m)($50.1 m)($48.5 m)
FY, 2013FY, 2014FY, 2015


$66.1 m$96.7 m$112.6 m

Accounts Receivable


$13 m$24.3 m$18.5 m

Current Assets

$244 m$519.1 m$556.5 m


$84.9 m$115.8 m$127.6 m


$39.7 m$39.7 m$39.7 m

Total Assets

$394.6 m$793.6 m$821.6 m

Accounts Payable

$52.6 m$50.4 m$57.8 m

Current Liabilities

$95.5 m$137.8 m$142.5 m

Additional Paid-in Capital

$145.9 m$225.5 m$263.4 m

Retained Earnings

($243.6 m)($293.7 m)($342.2 m)

Total Equity

$285.2 m$354.2 m$370 m

Financial Leverage

1.4 x2.2 x2.2 x
FY, 2013FY, 2014FY, 2015

Net Income

($18 m)($50.1 m)($48.5 m)

Accounts Receivable

($7 m)($17 m)$2.3 m


($5.3 m)($5.2 m)($387 k)

Accounts Payable

$17.3 m

Cash From Operating Activities

$15 m$9.2 m$31.1 m

Capital Expenditures

($47.5 m)($47 m)($37.7 m)

Cash From Investing Activities

($71 m)($325.7 m)($39.9 m)

Cash From Financing Activities

$26.6 m$349.2 m$27.5 m

Interest Paid

$109 k

Income Taxes Paid

$632 k

Free Cash Flow

$62.5 m$56.2 m$68.7 m

Cepheid Market Value History

Cepheid Median Salaries

Source: 30 public H-1B filings from Cepheid

Cepheid Online Presence

Cepheid News

Cepheid Company Life

You may also be interested in